This application is designed to study the mechanisms of transplantation tolerance with particular reference to the liver. The principal hypothesis driving these studies if the Principal Investigator's so- called """"""""Two-Way Paradigm"""""""". This proposes that the ultimate outcome of allograft transplantation represents the composite of two immunologic forces: classic host vs. graft attack, i.e. allograft rejection, and graft vs. host. The latter is an occult immunologic force at work. Although the clinical entity of graft vs. host disease in liver transplantation is uncommon, it represents in essence a serious effort by leukocytes contained in the graft to reject the recipient after their migration. Thus, it is the investigator's proposal that the recipient becomes populated with small numbers of cells from the donor organ and that the effect of this """"""""graft vs. host"""""""" reaction is the promotion of tolerance. As these cells leave the graft, they are replaced in the transplant by immune cells of the recipient in successful cases. In this hypothesis, host vs. graft disease if uncontrolled is bad because it leads to rejection of the allograft. The other way round, graft vs. host disease if unchecked can kill the patient, but if controlled it tempers rejection. The studies proposed will test this hypothesis. Moreover, the investigators will attempt to develop novel techniques to modify the number and character of the donor cells that ultimately reside in the recipient and promote tolerance to the allograft.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK029961-17
Application #
2391341
Study Section
Special Emphasis Panel (SRC (01))
Project Start
1981-01-01
Project End
2001-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
17
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Surgery
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Gandhi, Chandrashekhar R; Murase, Noriko; Starzl, Thomas E (2010) Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat kupffer cells. J Cell Physiol 222:365-73
Starzl, Thomas E; Fung, John J (2010) Themes of liver transplantation. Hepatology 51:1869-84
Shapiro, Ron; Basu, Amit; Tan, Henkie P et al. (2009) Kidney after nonrenal transplantation-the impact of alemtuzumab induction. Transplantation 88:799-802
Starzl, Thomas E; Barker, Clyde (2009) The origin of clinical organ transplantation revisited. JAMA 301:2041-3
Marsh, James W; Gray, Edward; Ness, Roberta et al. (2009) Complications of right lobe living donor liver transplantation. J Hepatol 51:715-24
Starzl, Thomas E (2008) Immunosuppressive therapy and tolerance of organ allografts. N Engl J Med 358:407-11
Thirunavukkarasu, Chinnasamy; Wang, Lian Fu; Harvey, Stephen A K et al. (2008) Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J Hepatol 48:578-88
Toyokawa, Hideyoshi; Nakao, Atsunori; Bailey, Robert J et al. (2008) Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl 14:346-57
Shapiro, Ron; Zeevi, Adriana; Basu, Amit et al. (2008) Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation 85:1125-32
Starzl, Thomas E (2007) Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res 38:6-41

Showing the most recent 10 out of 589 publications